Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Genetics & Molecular Biology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Cell Therapy 2024

About Conference


We welcome you all to attend 14th International Conference and Exhibition on Advanced Cell and Gene Therapy (Cell Therapy 2024) follows the theme Revolutionizing Healthcare: Advanced Cell & Gene Therapy which will be held during February 19-20, 2024 at London, UK. 

Cell and Gene Therapy Conferences is to ameliorate the knowledge, awareness, and education on Cell and Gene Therapy leading to the discovery of Genetic and Cellular Therapies which aid to alleviate the human disease as it is the most significant emerging technology in the eyes of Medical, Biotechnology, Pharmaceuticals and Academia. Cell and Gene Therapy Conference 2023 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. 

Cell Therapy Conferences will provide a perfect platform to all the Doctors, Researchers Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the respective sphere. Gene Therapy Conferences strategic astuteness is to be an event for bringing together Scientists, Physicians, International mix of leading Universities, Cell Gene Therapy Institutions to transform the practice of medicine by incorporating the use of genetic and Cellular Therapies to control and cure human disease.

This three-day Gene Therapy Event will address key issues concerning Cell and Gene Therapy in the broader context of Cellular and Genetic disorder. Organized around daily themes, the Conference focuses on moving from present knowledge to future solutions.

Target Audience

  • Cell Therapy Scientists, Researchers and Students
  • Molecular Medicine Scientists, Researchers and Students
  • Biotechnologists
  • Immunologists
  • Health-care professionals
  • Gene Therapy Researchers, Scientists and Students
  • Cell and Gene Therapy Faculties
  • Cell and Gene Therapy Associations and Societies
  • Universities and College students
  • Allied health professionals in the fields of Cell and Gene Therapy, hematology, oncology, neurology, family medicine and internal medicine
  • Stem Cell Students, Scientists
  • Stem Cell Researchers and Faculty
  • Stem Cell Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies

The forum of Scientists, students, research scholars and other professionals from all corners of the globe, come together to discuss future science. Each session of the meeting will be included with expert lectures, poster and discussions, join us to design sustainable processes, innovations by which and how these strategies drive new policies, advances the business and human health protection. We are glad to invite you on behalf of organizing committee to join us, where you are the decision maker for future at Cell and Gene Therapy 2024 congress.

Sessions

Track 01- Cell Therapy

Cell Therapy or Cytotherapy is the transfer of cells into a patient with a goal of improving the disease. From beginning blood transfusions were considered to be the first type of cell therapy to be practiced as routine. Later, Bone marrow transplantation has also become a well-established concept which involves treatment of much kind of blood disorders including anemia, leukemia, lymphoma and rare immunodeficiency diseases. Alternative medical practitioners perform cell therapy in the form of several different names including xeno transplant therapy, glandular therapy, and fresh cell therapy. It has been claimed by the proponents of cell therapy that it has been used successfully to repair spinal cord injuries, strengthen weaken immune system, treats autoimmune diseases like AIDS, help patients with neurological disorders like Alzheimer’s disease, Parkinson’s disease and epilepsy

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuropean Biophysics Programs - Biophysical SocietyEuropean Federation of Immunological SocietiesThierry Latran FoundationUK Stem Cell BankStem Cell Network North Rhine-WestphaliaCambridge Stem Cell InitiativeEuropean Society of Gene and Cell Therapy(ESGCT)EuroStemCell (European Consortium for Stem Cell Research).

United StatesAmerican Association of Integrative MedicineAlternative and Integrative Medical SocietyNorth Carolina Integrative Medicine SocietySociety for Integrative and Comparative BiologyCanadian Integrative Cancer Therapies Association.

AsiaTiantan Puhua Stem Cell Center ChinaAll India Institute of Medical Sciences (AIIMS)National Centre for Biological SciencesStem Cell Society SingaporeIndian Pancreas ClubTaiwan Society for Stem Cell ResearchAlzheimer’s Cure Foundation

 

Track 02- Gene Therapy

Gene Therapy basically involves the introduction or alteration of genetic material within a cell or organism with an intention of curing the disease. Both cell therapy and gene therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of Genetic diseases in DNA or cellular population respectively, the discovery of recombinant DNA technology in the 11270s provided tools to efficiently develop gene therapy. Scientists use these techniques to readily manipulate viral genomes, isolate genes and identify mutations involved in human disease, characterize and regulate gene expressions, and engineer various viral and non-viral vectors. Various long-term treatments for anemia, hemophilia, cystic fibrosis, muscular dystrophy, Gauscher’s disease, lysosomal storage diseases, cardiovascular diseases, diabetes and diseases of bones and joints are resolved through successful gene therapy and are elusive today.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuropean Society Of Gene And Cell TherapyCell SocietyBritish Society for Developmental BiologyEuropean Astrobiology Network AssociationFrench Societies for Cell BiologyFrench Society of Plant BiologyGerman society for cell biologyInternational Society for The Study Of The Origin Of Life And Astrobiology SocietyBritish Society for Cell Biology.

United StatesAmerican Society Of Gene And Cell TherapyCanadian Society of Biochemistry and Molecular & Cellular BiologyAmerican Society of Gene & Cell TherapyInternational Society For Computational BiologyAmerican Society for Cell BiologyInternational Society for Cell Biology and Biotech Protocols and ResearchSociety for Developmental BiologyStudent Society for Stem Cell ResearchThe Brazilian Society for Cell BiologyThe International Society for Systems BiologyThe Society for GlycobiologyThe Society for Mathematical Biology (Boulder CO, US)

AsiaUP Cell Biological SocietyThe Philippine Society for Cell BiologyStem Cell Society, The Korean Society For Molecular and Cellular BiologyIran Society for Cell BiologyChinese Society of Cell Biology.

 

Track 03- Stem Cell Therapies

Cell Therapy is defined as the therapy in which cellular material is injected into a patient in order to recover the healthy tissue. Cell therapy is targeted at many clinical indications in multiple organs by means of several modes of cell deliveryStem-Cell Therapy is the use of stem cells to treat or prevent a disease or condition. Stem cells are a class of undifferentiated cells which are able to differentiate into required or specialized cell types. Adult or somatic stem cells exist throughout the body after embryonic development and are found available inside the different types of tissue. The stem cell methodology includes the phases of Stem cell or progenitor cell engraftment, differentiation followed by long term replacement of damaged tissue.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeBritish Society for Developmental BiologyDutch Society For Developmental BiologyEuropean Society for Evolutionary Developmental BiologyFinnish Society for Developmental BiologyFrench Society for Developmental BiologySpanish Developmental Biology Society.

United StatesInternational Society for Developmental PsychobiologySociety for Developmental BiologySociety of Craniofacial Genetics and Developmental BiologySynthetic Biology ERC AssociationSynthetic Biology Center for Genetics and SocietyCanadian Society for Molecular Biosciences.

AsiaSociety for Conservation BiologyInternational Society for the Study of XenobioticsMarine Biological Association of IndiaAfrican Society for Bioinformatics and Computational BiologyAssociation of Asian Societies For Bioinformatics.

 

Track 04 - Stem Cell Research

In stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or serve as a way for the donor's immune system to fight some types of cancer and blood-related diseases, such as leukemia, lymphoma, neuro blastoma and multiple myeloma. These transplants use adult stem cells or umbilical cord blood.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuro Stem Cell (European Consortium for Stem Cell Research)German Stem Cell Network (GSCN)German Society for Stem Cell Research (GSZ), Stem Cell Network North Rhine-Westphalia (NRW)Norwegian Center for Stem Cell Research (NCSCR)

United StatesCalifornia Institute for Regenerative Medicine (CIRM)New York Stem Cell Foundation (NYSCF)Tissue Engineering International & Regenerative Medicine Society (TERMIS)International Society for Stem Cell Research (ISSCR)

AsiaThe New South Wales Stem Cell NetworkKorean Society for Stem Cell ResearchJapanese Society for Regenerative MedicineTaiwan Society for Stem Cell ResearchStem Cell Society Singapore (SCSS)

 

Track 05- Viral Gene Therapy

Classical methods of gene therapy include transfection. It became inefficient and limited mainly due to delivery of gene into actively proliferating cells invitro. Gene therapy utilizes the delivery of DNA into cells by means of vectors such as biological nanoparticles or viral vectors and non-viral methods. The Several kinds of viruses vectors used in gene therapy are retrovirus, adenovirus, adeno-associated virus and herpes simplex virus. While other recombinant viral vector systems have been developed, retroviral vectors remain the most popular vector system for gene therapy protocols and widest application due to their historical significance as the first vectors developed for efficient Gene Therapy application and the infancy of the field of Gene Therapy

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeUCSF Center for Systems and Synthetic BiologySBE- Society for Biological Engineering – AIChESynthetic Biology Industry AssociationEuropean association of synthetic biologyUK Bio industry AssociationsSynBio Society - Edinburgh University Students' Association.

United StatesThe Biomass Systems and Synthetic Biology Center FAPESP-BrazilUniversity of Minnesota Synthetic Biology SocietyThe International Association Synthetic Biology (IASB)Canadian Society for Molecular Biosciences.

AsiaAsian Society for Vascular BiologyAssociation of Synthetic Biology Brawijaya UniversitySystems Biology IEEE Control Systems SocietyAssociation for Tropical Biology and ConservationAssociation of Asian Societies For Bioinformatics.

 

Track 06-  Cell Culture and Bioprocessing

Stem-Cell line is a group of undifferentiated stem cells which is cultured invitro and can be propagated indefinitely. While stem cells can propagate indefinitely in culture due to their inherent cellular properties, immortalized cells would not normally divide indefinitely but have gained this ability to sustain due to mutation. The Immortalized cell lines can be generated from cells by means of isolating cells from tumors or induce mutations to make the cells immortal. An immortalized cell line is a population of multicellular organism cells which has not proliferates indefinitely. Due to mutation, the cells evaded normal cellular senescence and instead undergoing continuous cell division. A key factor in reducing the production costs of biopharmaceuticals is the development of cell lines which in turn produce a high yield of product.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeSynthetic Biology Industry AssociationUCSF Center for Systems and Synthetic BiologyEuropean association of synthetic biologyUK Bio industry AssociationsSynBio Society - Edinburgh University Students' AssociationSBE- Society for Biological Engineering – AIChE

United StatesUniversity of Minnesota Synthetic Biology SocietyThe Biomass Systems and Synthetic Biology Center FAPESP-BrazilThe International Association Synthetic Biology (IASB)Canadian Society for Molecular Biosciences

AsiaAssociation of Asian Societies For BioinformaticsSystems Biology IEEE Control Systems SocietyAsian Society for Vascular BiologyAssociation of Synthetic Biology Brawijaya UniversityAssociation for Tropical Biology and Conservation.

 

Track 07- Cell and Gene Therapy for Rare & Common Diseases

Gene Therapy is used to treat inherited Muscular disordercardiovascular disorder, HIV, cancer etc. In stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or as a way for the donor's immune system to provoke immunity against some types of cancer and blood-related diseases, such as leukemia. Cellular Therapy is internationally recognized for its novel approaches in treating blood related disorders like leukemia, lymphoma, myeloma, and other life-threatening diseases. The stem cell transplantation of hematopoietic stem cells (HSCT) in which the allogeneic hematopoietic stem cells are harvested from healthy donors of same species and autologous stem cell from the patient itself. Both therapies use high dosage cytotoxic medication in order to induce higher remission rates against malignant diseases. Autologous HSCT preferably used in relapsed malignant high-grade lymphoma and Allogeneic HSCT preferred for therapeutic effect against acute leukemia with unfavorable prognosis in a high percentage of patients. The Recent developments based on the expansion of the donor pool for allogeneic stem cells in order to reduce dosage as well as chemotherapeutic toxicity of allogeneic transplantation with sustainable anti-leukemia efficacy.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuro Stem Cell (European Consortium for Stem Cell Research)Cambridge Stem Cell Initiative United KingdomSwiss Stem Cell Network SwitzerlandNational Cancer Research Institute United KingdomThe Scottish Stem Cell Network Scotland United KingdomDanish Stem Cell Society

United StatesNew York Stem Cell FoundationInternational Society for Cellular Therapy USAStem Cell Clinical Trials USACentre for Genetics and Society USAInternational Society for Stem Cell Research USA

AsiaStem Cell Society SingaporeTaiwan Society for Stem Cell ResearchThe New South Wales Stem Cell Network AustraliaMalaysian Thoracic societyKorean Society for Stem Cell ResearchJapanese Society for Regenerative Medicine

 

Track 08- Tissue Engineering & Regenerative Medicine

Regenerative Medicine is the branch of translational research deals with the process of replacing, engineering or regenerating human cells, tissues or organs in order to restore or establish normal functionality of cell. Regenerative medicine is the combination of tissue engineering and Molecular Biology. Cell Therapy mediate cell repair via five primary mechanisms: providing an anti-inflammatory effect, homing to damaged tissues and recruiting other cells, such as endothelial progenitor cells for necessary tissue growth, supporting tissue remodelling over scar formation, inhibiting apoptosis programmable cell death, and differentiating tissues into bone, cartilage, tendon, and ligament tissue

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeSpanish National Cancer Research Centre (CNIO)Scan Balt Stem Cell Research NetworkNorwegian Center for Stem Cell ResearchLund Stem Cell Center SwedenStem Cell Network North Rhine-Westphalia.

United StatesGlobal Stem Cells Group USA, International Stem Cell Research USA, International Society for Cellular TherapyAmerican Academy of Anti-Aging MedicineInstitute for Stem Cell Biology and Regenerative Medicine at Stanford School of Medicine.

AsiaStem Cell Network Asia PacificSingapore Stem Cell SocietyNSW Stem Cell NetworkAustralian Society for Stem Cell ResearchIsrael Stem Cell Society

 

Track 09- Cell Science and Stem Cell Research

The extract derived from the plant cell culture technology is being harnessed and utilized as an active ingredient in anti-aging skincare products. In recent years, researchers have identified naturally occurring botanicals with substantial antioxidant activity proven to protect skin stem cells from UV-induced oxidative stress, inhibit inflammation, neutralize free radicals and reverse the effects of photo aging by means of anti-oxidant activity. Consequently, cosmeceutical products containing plant stem cell derived extracts have the ability to promote healthy cell proliferation and protect against UV-induced dermatological cellular damage in humans. In contrast to epidermal stem cells, plant stem cells are totipotent that they are capable of regenerating an entirely new, whole plant. Through innovative plant stem cell technology, scientists are able to extract tissue from botanicals and regenerate stem cells can be harnessed for use in humans. The use of stem cells derived from botanicals plant, rather than human stem cells, avoids the controversy surrounding the source or methods of extraction of human stem cells while still harnessing the potential of these intriguing cells and its effect in anti-photo aging.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeReliable Cancer Therapies BelgiumScan Balt Stem Cell Research NetworkDenmark Euro Stem Cell, Stem Cell Network NetherlandsGerman Stem Cell Network. United States USA: Regenerative Medicine FoundationAmerican Academy of Regenerative MedicineNIH Stem Cell CenterSociety of Surgical OncologyAmerican Institute for Cancer Research United States.

United StatesRegenerative Medicine FoundationAmerican Academy of Regenerative MedicineNIH Stem Cell Center, Society of Surgical Oncology, American Institute for Cancer Research United States.

Asia PacificJapanese Society for Regenerative MedicineKorean Society for Stem Cell ResearchSingapore Stem Cell SocietyTaiwan Society for Stem Cell ResearchInternational Society of Haematology Turkey

 

Track 10- Molecular Basis of Epigenetics

Epigenetics refers to changes in a chromosome which has influence on gene activity and expression. It is also used to describe any heritable phenotypic change that doesn't derive from a modification of the genome, such as prions. Epigenetics is the mechanism for storing and perpetuating or continuing indefinitely a “memory” at the cellular level. The basic molecular epigenetic mechanisms that are widely studied at present – regulation of chromatin structure of cell through histone post-translational modifications and covalent modification of DNA principally through the method of DNA methylation. Chromatin is a dynamic structure that integrates potentially hundreds of signals from the cell surface and has effects of coordinated and appropriate transcriptional response in cell. It is increasingly clear that epigenetic marking of chromatin and DNA itself is an important component of the cell signal integration of entire function that is performed by the genome. Moreover, the changes in the epigenetic state of chromatin in cell can have lasting effects on behavioural changes

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeDanish Stem Cell SocietyGerman Stem Cell NetworkEuro Stem CellStem Cell Network NetherlandsStem Cell Network North Rhine-Westphalia German.

United StatesAmerican Cancer SocietyCentre for Genetics and SocietyIPLASS International Placenta Stem Cell SocietyAmerican Society for Investigative Pathology United StatesStem Cell Clinical Trials.

Asia : International Society of Haematology TurkeyStem Cell Society SingaporeStem Cells AustraliaTaiwan Society for Stem Cell ResearchNew South Wales Stem Cell Network Australia

 

Track 11- Bioengineering Therapeutics

Tissue Engineering or Bioengineering is the combinational usage of cells, Engineering, materials methods, suitable biochemical and physicochemical factors in order to improve or replace the infected biological tissues. The field includes the development of materials, devices, techniques to detect and differentiate disease states, the treatment response, aid tissue healing, precisely deliver treatments to tissues or cells, signal early changes in health status, and provide implantable bio artificial replacement organs for recover or establish of healthy tissue .Techniques developed here identify and detect biomarkers of disease sub-types, progression, and treatment response, from tissue imaging to genetic testing and Single cell analysis, that aid the more rapid development of new treatments and guide their clinical applications in treating the disorder. It includes the usage of computational modeling, bioinformatics, and quantitative pharmacology to integrate data from diverse experimental and clinical sources to discover new drugs and specific drug targets, as well as to design more efficient and informative preclinical, clinical safety and efficacy studies.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuro Stem Cell (European Consortium for Stem Cell Research)German Stem Cell Network (GSCN)German Society for Stem Cell Research (GSZ), Stem Cell Network North Rhine-Westphalia (NRW)Norwegian Center for Stem Cell Research (NCSCR)

United StatesCalifornia Institute for Regenerative Medicine (CIRM)New York Stem Cell Foundation (NYSCF)Tissue Engineering International & Regenerative Medicine Society (TERMIS)International Society for Stem Cell Research (ISSCR)

AsiaThe New South Wales Stem Cell NetworkKorean Society for Stem Cell ResearchJapanese Society for Regenerative MedicineTaiwan Society for Stem Cell ResearchStem Cell Society Singapore (SCSS)

 

Track 12- Clinical Trials on Cell & Gene Therapy

Clinical Trials of Cell and Gene Therapy products often varying from the clinical trials design for other types of pharmaceutical products. This differences in trial design are necessitated by the distinctive features of these products. The clinical trials also reflect previous clinical experience and evidence of medicine. Early experiences with Cell and Gene Therapy products indicate that some CGT products may pose substantial risks to subjects due to effect at cellular and genetic level. The design of early-phase clinical trials of Cell and Gene Therapy products often involves the following consideration of clinical safety issues, preclinical issues, and chemistry, manufacturing and controls (CMC) issues that are encountered.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuropean Biophysics Programs - Biophysical SocietyEuropean Federation of Immunological SocietiesThierry Latran FoundationUK Stem Cell BankStem Cell Network North Rhine-WestphaliaCambridge Stem Cell InitiativeEuropean Society of Gene and Cell Therapy(ESGCT)EuroStemCell (European Consortium for Stem Cell Research).

United StatesAmerican Association of Integrative MedicineAlternative and Integrative Medical SocietyNorth Carolina Integrative Medicine SocietySociety for Integrative and Comparative BiologyCanadian Integrative Cancer Therapies Association.

AsiaTiantan Puhua Stem Cell Center ChinaAll India Institute of Medical Sciences (AIIMS)National Centre for Biological SciencesStem Cell Society SingaporeIndian Pancreas ClubTaiwan Society for Stem Cell ResearchAlzheimer’s Cure Foundation

 

Track 13- Nano Therapy

Diseases can be treated using viruses as vector to deliver genes in Gene Therapy. Viruses as gene vector, however, can themselves cause problems in that they may initiate inflammation and the genes may be expressed at too high a level or for too long period of exposure. The goal of Nano Technology in gene therapy is delivery of therapeutic genes without a virus, using nanoparticles as non-viral vector to deliver the genes. The particles can be made with multiple layers so the outer layer with covering of peptide that can target the particles to cells of interest at specific site. The emergent Nanotechnology in gene therapy is used to develop unique approaches in treating the retinopathies and the development of micro and Nano dimensional artificial antigen presenting cells (aAPCs) for cancer immunotherapy. These aAPCs mimic the natural signals in immunity that killer T-cells receive when there is an invader (bacteria, virus, cancer cell, etc.) in the body.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuropean Society Of Gene And Cell TherapyCell SocietyBritish Society for Developmental BiologyEuropean Astrobiology Network AssociationFrench Societies for Cell BiologyFrench Society of Plant BiologyGerman society for cell biologyInternational Society for The Study Of The Origin Of Life And Astrobiology SocietyBritish Society for Cell Biology.

United StatesAmerican Society Of Gene And Cell TherapyCanadian Society of Biochemistry and Molecular & Cellular BiologyAmerican Society of Gene & Cell TherapyInternational Society For Computational BiologyAmerican Society for Cell BiologyInternational Society for Cell Biology and Biotech Protocols and ResearchSociety for Developmental BiologyStudent Society for Stem Cell ResearchThe Brazilian Society for Cell BiologyThe International Society for Systems BiologyThe Society for GlycobiologyThe Society for Mathematical Biology (Boulder CO, US)

AsiaUP Cell Biological SocietyThe Philippine Society for Cell BiologyStem Cell Society, The Korean Society For Molecular and Cellular BiologyIran Society for Cell BiologyChinese Society of Cell Biology.

 

Track 14- Genome Editing

Genome editing with engineered nucleases (GEEN) is emergent type of Genetic Engineering. GEEN is the technology in which DNA is inserted, deleted or replaced in the genome. The emergence of highly versatile genome-editing technologies has provided investigators with the ability to rapidly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It also promotes various changes in sub cellular level. Genome Editing itself also holds tremendous potential for treating the underlying various idiopathic genetic causes of certain diseases. The core technologies now most commonly used techniques to facilitate genome editing are clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 12 (Cas12), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and homing endonucleases or mega nucleases.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeBritish Society for Developmental BiologyDutch Society For Developmental BiologyEuropean Society for Evolutionary Developmental BiologyFinnish Society for Developmental BiologyFrench Society for Developmental BiologySpanish Developmental Biology Society.

United StatesInternational Society for Developmental PsychobiologySociety for Developmental BiologySociety of Craniofacial Genetics and Developmental BiologySynthetic Biology ERC AssociationSynthetic Biology Center for Genetics and SocietyCanadian Society for Molecular Biosciences.

AsiaSociety for Conservation BiologyInternational Society for the Study of XenobioticsMarine Biological Association of IndiaAfrican Society for Bioinformatics and Computational BiologyAssociation of Asian Societies For Bioinformatics.

 

Track 15- Advanced Gene Therapeutics

Functionality of biomaterials for these forms is depends upon the chemical reaction such as localized or systemic response at the surface tethered moieties or encapsulated therapeutic factors such as drugsgenes, cells, growth factors, hormones and other active agents to specific target sites. The application of functional biomaterials is rehabilitation, reconstruction, regeneration, repair, ophthalmic applications and act as therapeutic solutions. It has the property of biocompatibility and produce inertness response to the tissue. The biomaterial-mediated gene therapy aim to use polymeric gene therapy systems to halt the progression of neuron loss through Neuro protective routes and it combine stem cell therapy and biomaterial delivery system in order to enhance regeneration or repair after ischemic injury.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeUCSF Center for Systems and Synthetic BiologySBE- Society for Biological Engineering – AIChESynthetic Biology Industry AssociationEuropean association of synthetic biologyUK Bio industry AssociationsSynBio Society - Edinburgh University Students' Association.

United StatesThe Biomass Systems and Synthetic Biology Center FAPESP-BrazilUniversity of Minnesota Synthetic Biology SocietyThe International Association Synthetic Biology (IASB)Canadian Society for Molecular Biosciences.

AsiaAsian Society for Vascular BiologyAssociation of Synthetic Biology Brawijaya UniversitySystems Biology IEEE Control Systems SocietyAssociation for Tropical Biology and ConservationAssociation of Asian Societies For Bioinformatics.

 

Track 16- Genetics & Genomic Medicine

Genetics in Health and Disease in which therapy utilizes genetics, imaging and biological indicators to understand predisposition to disease, what constitutes health during childhood and throughout the life course. Gene and Protein Function are used to develop tools, skills and resources to elucidate gene function and to inform development of new therapies using state-of the-art technologies. Personalised Medicine and Patient benefit is considered to ensure basic science discoveries of disease mechanisms and patient’s genomes are used to produce best effect to improve patients’ lives which include better diagnostics, identification of biomarkers and targeting of therapies.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeSynthetic Biology Industry AssociationUCSF Center for Systems and Synthetic BiologyEuropean association of synthetic biologyUK Bio industry AssociationsSynBio Society - Edinburgh University Students' AssociationSBE- Society for Biological Engineering – AIChE

United StatesUniversity of Minnesota Synthetic Biology SocietyThe Biomass Systems and Synthetic Biology Center FAPESP-BrazilThe International Association Synthetic Biology (IASB)Canadian Society for Molecular Biosciences

AsiaAssociation of Asian Societies For BioinformaticsSystems Biology IEEE Control Systems SocietyAsian Society for Vascular BiologyAssociation of Synthetic Biology Brawijaya UniversityAssociation for Tropical Biology and Conservation.

 

Track 17- Ethical Issues in Cell and Gene Therapy

The global market for cell and gene-based therapies is expected to surpass the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell – based therapies are high impact disease areas with significant incurable needs, including cancerheart diseaseneurodegenerative diseases, musculoskeletal disorders and autoimmune diseases. Gene therapies should then not be rushed to market, but companies should gather the required data about the impact of therapy in human community with the appropriate duration of follow-up to allow proper evaluation by payers. In addition, it is key to think about potential reimbursement of the techniques and also the pricing strategies, including risk sharing, as soon as the early clinical development phase

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuro Stem Cell (European Consortium for Stem Cell Research)Cambridge Stem Cell Initiative United KingdomSwiss Stem Cell Network Switzerland, National Cancer Research Institute United Kingdom, The Scottish Stem Cell Network Scotland United KingdomDanish Stem Cell Society.

United StatesNew York Stem Cell FoundationInternational Society for Cellular Therapy USAStem Cell Clinical Trials USACentre for Genetics and Society USAInternational Society for Stem Cell Research USA

AsiaStem Cell Society SingaporeTaiwan Society for Stem Cell ResearchThe New South Wales Stem Cell Network AustraliaMalaysian Thoracic societyKorean Society for Stem Cell ResearchJapanese Society for Regenerative Medicine

 

Track 18- Cell Therapy for Cardiovascular and Neurological Disorders

Cardiovascular diseases have become an increasing clinical issue globally. A new challenge in the treatment of the cardiovascular disease is cellular transplantation or cellular cardiomyopathy. Acute ischaemic injury and chronic cardiomyopathies lead to permanent loss of cardiac tissue and ultimately heart failure. Current therapies wide aim to attenuate the pathological changes that occur when injury and to scale back risk factors of vas diseases. However, they do not improve the patient's quality of life or the prognosis more than moderate. Different types of stem cells have been used for Stem Cell Therapy.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeSpanish National Cancer Research Centre (CNIO)Scan Balt Stem Cell Research NetworkNorwegian Center for Stem Cell ResearchLund Stem Cell Center SwedenStem Cell Network North Rhine-Westphalia.

United StatesGlobal Stem Cells Group USA, International Stem Cell Research USA, International Society for Cellular TherapyAmerican Academy of Anti-Aging MedicineInstitute for Stem Cell Biology and Regenerative Medicine at Stanford School of Medicine.

AsiaStem Cell Network Asia PacificSingapore Stem Cell SocietyNSW Stem Cell NetworkAustralian Society for Stem Cell ResearchIsrael Stem Cell Societ

 

Track 19- Markets & Future Prospects for Cell & Gene Therapy

The enormous number of companies involved in Cell Therapy has increased progression remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 305 of these are profiled 2121 alliances. Of these companies, 170 are involved in stem cells. The Profiles of 72 academic institutions in the US involved in cell therapy along with their commercial collaborations. Allogeneic technology with more than 350 clinical trials is poised to dominate the commercialization of cell therapies in market. Further RandD in cell and gene therapy is expected to bloom given the biologically based advantages.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeEuro Stem Cell (European Consortium for Stem Cell Research)German Stem Cell Network (GSCN)German Society for Stem Cell Research (GSZ), Stem Cell Network North Rhine-Westphalia (NRW)Norwegian Center for Stem Cell Research (NCSCR)

United StatesCalifornia Institute for Regenerative Medicine (CIRM)New York Stem Cell Foundation (NYSCF)Tissue Engineering International & Regenerative Medicine Society (TERMIS)International Society for Stem Cell Research (ISSCR)

AsiaThe New South Wales Stem Cell NetworkKorean Society for Stem Cell ResearchJapanese Society for Regenerative MedicineTaiwan Society for Stem Cell ResearchStem Cell Society Singapore (SCSS)

 

Track 20- Regulatory and Safety Aspects of Cell and Gene Therapy

Cell therapy products require a variety of safety considerations. Stem cell and gene products are heterogeneous substances. There are several areas that particularly need to be addressed as it is quite different from that of pharmaceuticals. These range from creating batch consistency, product stability to product safety, strength and efficacy through pre-clinical, clinical studies and marketing authorization. This review summarizes the existing regulations/guidelines in US, EU, India, and the associated challenges in developing SCBP with emphasis on clinical aspect.

Recommended Gene Therapy Conferences | Cell Therapy ConferencesStem Cell Conferences | Cell and Gene Therapy Events | Cell and Gene Therapy Conferences 2023

Related Societies

EuropeDanish Stem Cell Society,German Stem Cell NetworkEuro Stem CellStem Cell Network NetherlandsStem Cell Network North Rhine-Westphalia German.

United StatesAmerican Cancer SocietyCentre for Genetics and SocietyIPLASS International Placenta Stem Cell SocietyAmerican Society for Investigative Pathology United StatesStem Cell Clinical Trials.

Asia : International Society of Haematology TurkeyStem Cell Society SingaporeStem Cells AustraliaTaiwan Society for Stem Cell Research, New South Wales Stem Cell Network Australia.

Market Analysis

Importance & Scope:

Scope: The Scope of the conference is to gather all the Doctors, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the respective sphere. This Cell and Gene Therapy Conference is the premier event focusing on understanding individual and organizational behavior and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals and academia.

Importance: Conference on Cell & Gene Therapy is a much celebrated conference which basically deals with the latest research and developments in the sphere of Cell and molecular biology. This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with Ph.D. Students to come and inform all the attendees about the latest scientific advancements on the respective sphere.

Global Cell Therapy Market 2016-2027

Cell Therapy market during the estimate time of 2016 to 2022. The market is required to arrive at USD 161.8 million by 2022, developing at a CAGR of 11.0% during the conjecture time frame. Factors, for example, the developing mindfulness identified with the helpful power of immature microorganisms in illness the executives, improvement of cutting edge genome-based cell investigation procedures, expanding public-private speculations for undifferentiated organism research, recognizable proof of new undeveloped cell lines, and advancements in foundation for foundational microorganism banking and handling are pushing the development of the worldwide undifferentiated organism treatment market.

Based on method of treatment, the worldwide undifferentiated organism treatment market is partitioned into two significant classifications, specifically, allogeneic immature microorganism treatment and autologous undeveloped cell treatment. The allogeneic foundational microorganism treatment fragment is relied upon to order the biggest portion of 95.2% in the worldwide undifferentiated organism treatment market in 2017 developing at a CAGR of 11.2% during the estimate time frame. This huge offer can essentially be ascribed to the rising commercialization of allogeneic foundational microorganism treatment items, more extensive remedial utilizations of allogeneic undifferentiated organisms, simple creation scale-up cycle, and developing number of clinical preliminaries identified with allogeneic undeveloped cell treatments.

Based on restorative application, the worldwide immature microorganism treatment market is fragmented into musculoskeletal issues, wounds and wounds, cardiovascular infections, medical procedures, gastrointestinal sicknesses, and different applications. The musculoskeletal issues portion is relied upon to order the biggest portion of 61.1% in the worldwide immature microorganism treatment market in 2017. Moreover, the CVS illnesses portion is relied upon to develop at the most elevated CAGR of 13.0% during the figure time frame. This huge offer can be ascribed to the rising accessibility of undifferentiated organism based items for the treatment of musculoskeletal problems, high predominance of musculoskeletal issues and bone and joint sicknesses, and developing patient inclination for viable and early therapy systems.

Based on cell source, the worldwide foundational microorganism treatment market is partitioned into fat determined MSCs; bone marrow inferred MSCs, undeveloped/line blood SCs, and other cell sources. The fat determined MSCs section was required to represent the biggest portion of 59.1% in the worldwide foundational microorganism treatment market in 2017. Besides, the bone marrow determined MSCs portion is relied upon to develop at most elevated CAGR of 12.1% during the conjecture time frame.

North America is required to be the biggest local fragment in the worldwide undifferentiated cell treatment market in 2017, trailed by Asia-Pacific. What's more, the North American undifferentiated cell treatment market is relied upon to be the quickest developing locale during the figure time frame, developing at a CAGR of 11.5%. Factors, for example, developing mindfulness identified with the restorative power of undifferentiated organisms, expanding number of clinical preliminaries for foundational microorganism based items, and expanding public-private subsidizing and examination awards are driving the development of this market.

List of Companies Associated with Cell and Gene Therapy Research

  • Dendron
  • Mesoblast
  • Vericel
  • AlloCure
  • Amorcyte
  • Anterogen
  • Antibe Therapeutics
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • AxoGen
  • Bellicum Pharmaceuticals
  • BioCardia
  • BIOCELLULAR THERAPIES
  • Biogen Idec
  • Bio-Tissue
  • BIOTIME
  • BioTissue Technologies
  • BrainStorm Cell Therapeutics
  • Bluebird Bio
  • Bone Therapeutics
  • Caladrius
  • Capricor Therapeutics
  • CellBioMed
  • Celgene
  • Cell Medica
  • CellPraxis
  • CellSeed
  • Cell Therapy
  • Celyad
  • CESCA THERAPEUTICS
  • CRC for Cell Therapy Manufacturing
  • CryoLife
  • Cynata Therapeutics
  • Cytori Therapeutics
  • DiscGenics
  • Fate Therapeutics
  • Fibrocell Science
  • Forticell Bioscience
  • Fortress Biotech
  • Gamida Cell
  • GlaxoSmithKline
  • Healthpoint
  • Histogen
  • Histogenics
  • Holostem Terapie Avanzate
  • Humacyte
  • Immunocellular Therapeutics
  • Integra Life Sciences
  • Intercytex
  • iSTO Technologies
  • Janssen Pharma
  • Juno Therapeutics
  • Juventas Therapeutics
  • Kensey Nash
  • Kite Pharma
  • Kiadis Pharma
  • LifeNet Health
  • Living Cell Technologies
  • Lonza
  • MaxCyte
  • MEDIPOST
  • Nanofiber Solutions
  • Nanotope
  • Neuralstem
  • Newlink Genetics
  • Northwest Biotherapeutics
  • NovaRx
  • Ocata Therapeutics
  • Opexa Therapeutics
  • Orbsen Therapeutics
  • Pfizer
  • Pharmicell
  • Pluristem Therapeutics
  • Prima BioMed
  • Q Therapeutics
  • Regenerexx
  • Regeneus
  • Regenerys
  • Regience
  • Regrow
  • RepliCel
  • ReproCELL
  • ReNeuron
  • RenovaCare
  • RESSTORE
  • RhinoCyte
  • Rohto Pharmaceutical
  • SanBio
  • Sangamo BioSciences
  • Shanghai Sunway Biotechm
  • Shire Regenerative Medicine
  • StemCells
  • STEMPEUTICS RESEARCH
  • Synergistic Technologies
  • t2cure
  • Takara Bio
  • Tella
  • Tengion
  • TissueGene
  • Tessa Therapeutics
  • Txcell
  • VentriNova
  • ViaCyte
  • VistaGen Therapeutics
  • SDRMI and Xcelthera

Top Major Societies Associated with Cell and Gene Therapy

  • British Society and Gene and Cell Therapy
  • American Society of Gene and Cell Therapy (ASGCT)
  • Australasian Gene Therapy Society (AGTS)
  • Austrian Network for Gene Therapy
  • British Society of Gene Therapy (BSGT)
  • European Society of Gene and Cell Therapy (ESGCT)
  • Finnish Gene Therapy Society (FGTS)
  • German Gene Therapy Society (DGGT)
  • International Society for Cancer Gene Therapy (ISCGT)
  • Irish Society for Gene & Cell Therapy (ISGCT)
  • Israeli Society of Gene & Cell Therapy (ISGCT)
  • Japan Society of Gene Therapy (JSGT)
  • Korean Society of Gene and Cell Therapy (KSGCT)
  • Netherlands Society of Gene and Cell Therapy (NVGCT)
  • Société Francophone de ThérapieCellulaire et Génique (SFTCG)
  • Spanish Society of Gene and Cell Therapy (SETGyC)
  • Swedish Society for Gene and Cell Therapy (SSGCT)
  • Turkish Society of Gene & Cell Therapy (TSGCT)

Learn More

Cell therapy Related Journals:

 

Cell Therapy Universities:

Cell Therapy Hospitals:

Cell Therapy Target Audience:

To Collaborate Scientific Professionals around the World

Conference Date February 19-20, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Molecular and Genetic Medicine Journal of Human Genetics and Embryology Journal of Cellular and Molecular Biology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by